Univariate Analysis for CMV Disease and Infection in Patients With MM, HD, and NHL
Group . | (A) CMV Disease . | (B) CMV Infection . | ||||||
---|---|---|---|---|---|---|---|---|
No. of Events/Total (%) . | OR . | P Value . | 95% CI . | No. of Events/Total (%) . | OR . | P Value . | 95% CI . | |
CD34-selected | 7/17 (41) | 17.0 | <.001 | 3.8-76.7 | 6/12 (50) | 3.4 | .06 | 1.0-12.1 |
Unselected | 3/76 (3.9) | 15/66 (22.7) |
Group . | (A) CMV Disease . | (B) CMV Infection . | ||||||
---|---|---|---|---|---|---|---|---|
No. of Events/Total (%) . | OR . | P Value . | 95% CI . | No. of Events/Total (%) . | OR . | P Value . | 95% CI . | |
CD34-selected | 7/17 (41) | 17.0 | <.001 | 3.8-76.7 | 6/12 (50) | 3.4 | .06 | 1.0-12.1 |
Unselected | 3/76 (3.9) | 15/66 (22.7) |